Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD

NCT06364319 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

cGVHD

Interventions

DRUG: anti-CD25 rhMAb
DRUG: Prednisone
DRUG: Ruxolitinib
DRUG: Cyclosporine

Sponsor

Peking University People's Hospital